mfgiola: Thanks for the info re Roche apparently considering Oncolytics as a partner in pancreatic cancer. If Roche already has found its dance partner for turning cold tumors hot, then I would be back to thinking GSK and its ICI, Jemperli (which omitted, perhaps inadvertently, from Riz's list of PD-1 inhibitors). In terms of a partner announcement by Dr Jay, either tomorrow or soon, I continue to infer from CYDY's Munich, Barcelona, Vienna dance card that our partner will be an Europe based BP.

Stay tuned.